Dyne Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
DYN
CUSIP
26818M108
Type
Equity
Class
COM
Num filings
255
Total reported value, excl. options
$4.37 B
Manager Report Date Value ($000) Shares Option Type